Our Mission

Axonis Therapeutics is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders, in order to make a real difference for patients, their families, and the global healthcare system.

Board of Directors

COREY GOODMAN, Ph.D.

Executive Chairman & Co-Founder

JOANNA STANICKA, Ph.D.

CEO, President & Co-Founder

BOB YANT

Board Director & Co-Founder

RICHARD SIPOS

Board Director

MARCELO BIGAL, M.D., Ph.D.

Chief Medical Advisor & Board Observer

JOHN KINCAID

Chief Drug Development Advisor & Board Observer

JEFF STEVENS, M.B.A.

Board Observer

Scroll to Top